Government Affairs
Refine Search
Pharmaceutical
A powerful committee of the freshly inaugurated Democrat-led US House of Representatives has launched a far-ranging investigation into the drug pricing practices of the US pharmaceutical industry. 15 January 2019
Pharmaceutical
The US House of Representatives last week approved two more pieces of legislation to reopen key parts of the federal government and provide certainty to American families affected by the Trump Shutdown. 15 January 2019
Pharmaceutical
The USA is a 'better country' than one that forces its people to decide between paying their bills or their prescriptions, a Democrat has said as he joined colleagues in proposing a sweeping plan to lower drug prices. 11 January 2019
Biotechnology
US President Donald Trump's administration has been criticized for continuing to defend 'flawed' proposals for changing the way that Medicare drug prices are set. 11 January 2019
Pharmaceutical
With next to no news releases coming out of government departments due to the virtual government shut down, Health and Human Service Secretary Alex Azar is expressing his frustrations on Twitter regarding continued pressure on drug pricing. 11 January 2019
Pharmaceutical
Now into the third week of the virtual US government shut down due to Democrats refusing to agree budget requests (notably building a wall on the Mexico/America border), government activities at various agencies, including the US Food and Drug Administration, are feeling the heat. 10 January 2019
Biotechnology
The government-backed Cell and Gene Therapy (CGT) Catapult has boasted that the UK’s pipeline of advanced therapy medicinal products continues to go from strength to strength. 8 January 2019
Pharmaceutical
As was the case in 2018, drug pricing pressure from regulators, patients, politicians and payers will remain through 2019 and aggressive negotiation tactics to drive down drug prices are expected. 4 January 2019
Generics
The issue of US drug pricing and what government action might be taken to lower prices are getting as many headlines as ever at the start of 2019, but China is currently providing more striking evidence of action on cutting drugmakers’ margins. 3 January 2019
Pharmaceutical
The Community Oncology Alliance (COA) recently submitted formal comments to the Centers for Medicare and Medicaid Services (CMS) regarding the Medicare Program International Pricing Index Model for Medicare Part B Drugs pre-proposed rule, also known as the IPI Model. 3 January 2019
Pharmaceutical
The Russian government has expanded the list of vital and essential drugs from 699 to 735 items for 2019, according to recent statements by the press-service of Russia’s Prime Minister Dmitry Medvedev, reports The Pharma Letter’s local correspondent. 26 December 2018
Pharmaceutical
Russia’s pharmaceutical industry professional associations last week called for maintaining the technical conditions for implementing the project for monitoring the movement of medicines within the framework of the requirements developed earlier in the pilot project. 24 December 2018
Pharmaceutical
The US Department of Justice obtained more than $2.8 billion in settlements and judgments from civil cases involving fraud and false claims against the government in the fiscal year ending September 30, 2018, it was announced on Friday. 24 December 2018
Biotechnology
China, with its reformed priority review and approval processes, is supporting biotech revolution in the country and thereby allowing domestic drug developers to compete with well-established multinational counterparts. 21 December 2018
Pharmaceutical
Pharma trade group Medicines Australia has welcomed today’s Mid-Year Economic and Fiscal Outlook (MYEFO), announced by Treasurer Josh Frydenberg. 17 December 2018
Pharmaceutical
The Russian government has adopted a new method for determining the prices for vital and essential drugs, according to an official spokesman of Russian Minister of Health Veronika Skvortsova, reports The Pharma Letter’s local correspondent. 13 December 2018
Pharmaceutical
The World Health Organization (WHO) says that Tanzania has become the first country in Africa to achieve a “well-functioning regulatory system for medical products.” 12 December 2018
Pharmaceutical
The US House of Representatives has approved a bill that would prevent drugmakers from overcharging Medicaid in the way Mylan (Nasdaq: MYL) was famously accused of doing. 12 December 2018
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has named David Ricks, the chairman and chief executive of US pharma major Eli Lilly, as its new president. 11 December 2018
Pharmaceutical
Just head of UK Prime Minister Theresa May’s decision was announced to postpone the parliamentary vote on the Brexit withdrawal declaration that was due on Tuesday, the European Federation of Pharmaceutical Industries and Associations (EFPIA) today issued another warning about the implications for the pharma industry. 10 December 2018
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze